...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: PAH Trial now recruiting

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study (APPRoAcH-p)

https://clinicaltrials.gov/ct2/show/NCT03655704

ClinicalTrials.gov Identifier: NCT03655704

Recruitment Status  : Recruiting

First Posted  : August 31, 2018

Last Update Posted  : August 30, 2019

Share
New Message
Please login to post a reply